CN111685244A - 药食同源植物型饮料及其制备方法 - Google Patents
药食同源植物型饮料及其制备方法 Download PDFInfo
- Publication number
- CN111685244A CN111685244A CN202010583106.4A CN202010583106A CN111685244A CN 111685244 A CN111685244 A CN 111685244A CN 202010583106 A CN202010583106 A CN 202010583106A CN 111685244 A CN111685244 A CN 111685244A
- Authority
- CN
- China
- Prior art keywords
- decoction
- parts
- seed
- beverage
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 235000018927 edible plant Nutrition 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 18
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 15
- 238000010025 steaming Methods 0.000 claims abstract description 15
- 238000002791 soaking Methods 0.000 claims abstract description 14
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 11
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 10
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 10
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 10
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 10
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 10
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 10
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 10
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 10
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 10
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 10
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 10
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 10
- 240000004153 Hibiscus sabdariffa Species 0.000 claims abstract description 10
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims abstract description 10
- 240000000249 Morus alba Species 0.000 claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 10
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 10
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 10
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 7
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 5
- 244000010000 Hovenia dulcis Species 0.000 claims abstract description 5
- 235000008584 Hovenia dulcis Nutrition 0.000 claims abstract description 5
- 241000756042 Polygonatum Species 0.000 claims abstract description 5
- 210000003813 thumb Anatomy 0.000 claims abstract description 3
- 244000088415 Raphanus sativus Species 0.000 claims abstract 4
- 239000007788 liquid Substances 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 23
- 244000068988 Glycine max Species 0.000 claims description 21
- 235000010469 Glycine max Nutrition 0.000 claims description 21
- 238000001914 filtration Methods 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 241000218236 Cannabis Species 0.000 claims description 15
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 12
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 12
- 241000245665 Taraxacum Species 0.000 claims description 9
- 240000006365 Vitis vinifera Species 0.000 claims description 8
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 8
- 238000007654 immersion Methods 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 6
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 6
- 240000001972 Gardenia jasminoides Species 0.000 claims description 5
- 241001633680 Polygonatum odoratum Species 0.000 claims description 5
- 239000013505 freshwater Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 4
- 240000005809 Prunus persica Species 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 27
- 239000008280 blood Substances 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 18
- 210000004185 liver Anatomy 0.000 abstract description 12
- 230000008961 swelling Effects 0.000 abstract description 6
- 238000001816 cooling Methods 0.000 abstract description 5
- 238000002560 therapeutic procedure Methods 0.000 abstract description 5
- 239000003205 fragrance Substances 0.000 abstract description 4
- 210000000232 gallbladder Anatomy 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 3
- 230000004438 eyesight Effects 0.000 abstract description 3
- 230000002045 lasting effect Effects 0.000 abstract description 3
- 238000010926 purge Methods 0.000 abstract description 3
- 230000000378 dietary effect Effects 0.000 abstract description 2
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 240000004308 marijuana Species 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 20
- 239000003814 drug Substances 0.000 description 15
- 230000006870 function Effects 0.000 description 15
- 235000013305 food Nutrition 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 241000220259 Raphanus Species 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000007721 medicinal effect Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000035762 Disorder of lipid metabolism Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 241001593968 Vitis palmata Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- -1 flavonoid compounds Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本专利申请提供了一种药食同源植物型饮料及其制备方法技术方案,本饮料选用蒲公英、玉竹、马齿苋、葛根、莱菔子、栀子、枳椇子、山楂、火麻仁、砂仁、决明子、桃仁、玫瑰茄、佛手、桑葚、橘皮,分别实施浸泡、蒸制、煎煮、再混合煎煮的工艺方法制得饮料,具有清爽的药香且香气持久,质感清澈、透明,具有清热解毒、消肿散结、清肝明目、护肝利胆、泻火除燥、凉血解毒的食疗特医作用。
Description
技术领域
本专利申请涉及食用饮品及其制备方法。
背景技术
目前的非酒精饮料品种虽多,但多以满足人体水份补给基本生理需求而设计制造,产品注重解渴、提神、补充食用营养等方面引导消费。但现有非酒精饮料,普遍为主打种类不多的一种或两种原料的饮料,再配用口感调整的添加剂,如乳饮料、咖啡饮料、运行型功能饮料等,存在产品口味、作用单一化的技术问题,而且复合添加成份多为食用型化学成份,且用量占比较大,口味人工合成感强、口感不柔和,导致饮料口味、气味乏善可陈。虽有部分饮料产品以中草药原料制备,但产品制备工艺较为粗犷,要不是没有在口感、口味等方向有更严格技术要求,药性混合气味浓重、让饮用者感觉不舒适、不清爽、产品品相不理想,生产者多以良药苦口传统意识来隐盖其技术不足,要不就因为强调口感和饮料清澈上的考虑而导致原料成份含量较低。
发明内容
本专利申请发明目的在于开发新型以多种天然植物类物质、特别是选用“药食同源”目录中十多种植物类物料为原料制备饮料,克服集成十多种多元化“药食同源”植物物料制饮料必然出现的质感浑浊、中药混合气味浓重、刺激性强、且口味、气味混杂、让饮用者难以接受的技术问题,提供一种药食同源植物型饮料及其制备方法,其制备方法具有原料成份高提取率,在最大限度的保存药食同源原料的食疗成份的基础上,还要避免其口感、气味、质感上偏于药性,使之具有口感清爽、药香层次感强、留香持久、质感清澈、透明、色泽沉稳、深红中难掩金黄,满足作为饮料的安身之本需求之上,还充分发挥了其调整生理机能的健康功效。
本专利申请提供的药食同源植物型饮料技术方案,其主要技术内容是:一种药食同源植物型饮料,其特征在于,该饮料为蒲公英、玉竹、马齿苋、葛根、莱菔子、栀子、枳椇子、山楂、火麻仁、砂仁、决明子、桃仁、玫瑰茄、佛手、桑葚、橘皮的混合提取液,添加甜度调节添加剂制备得到。
本专利申请还提供了一种上述药食同源植物型饮料的制备方法,其原料按绝干重量份计,分别为:
蒲公英 20-40份
佛手 5-10份
马齿苋 7-12份
玉竹 20-40份
栀子 7-12份
葛根 5-12份
莱菔子 10-20份
桑葚 10-20份
玫瑰茄 50-90份
山楂 20-40份
枳椇子 5-12份
桃仁 3-9份
决明子 5-15份
砂仁 5-12份
火麻仁 5-12份
橘皮 5-12份
其制备工艺方法:
第①步,加水,浸泡洗净后的玫瑰茄、栀子,浸泡不少于24小时,过滤取其浸液,备用;
第②步,佛手、玉竹、橘皮、砂仁和葛根清理干净,粉碎至黄豆颗粒大小,加入莱菔子,置入容器中加水浸泡至发软后,再隔水加压蒸制,过滤取蒸液,备用;
第③步,蒲公英、马齿苋、山楂、桑葚洗净,加水浸泡至发软后煎煮,过滤取煎煮液,备用;
第④步,将第①、②、③步的浸液、蒸液和煎煮液混合,备用;
第⑤步,用第④步的混合液的一部分浸泡洗净的决明子、枳椇子、火麻仁和桃仁,浸透后一同煎煮,过滤取一次煎煮汁;余下混合液至少一次与前次滤出物料再次煎煮,过滤取煎煮汁,将煎煮汁合一,由甜酸添加剂,调配口感,常规杀菌、灌装制备得到。
上述整体技术方案的之一优选技术手段,第②步的加压蒸制工艺为:压力不低于0.2MPa蒸制10分钟。
上述整体技术方案的之一优选技术手段,第③步为小火煎煮20分钟。
上述整体技术方案的之一优选技术手段,第③步为三次煎煮,一次煎煮后的滤出物料补新水实施二次煎煮,过滤取二次煎煮液,二次煎煮后的滤出物料补新水实施三次煎煮,过滤取三次煎煮液,三次煎煮液合一,每次补水量不超过第一次加水量的1/3。
上述整体技术方案的之一优选技术手段,第①步的浸液、第②步的蒸液、第③步的煎煮液,按重量比1:1-2:1-2混合,得混合液。
上述整体技术方案的之一优选技术手段,其第⑤步,用不少于第④步混合液的一半浸泡洗净的决明子、枳椇子、火麻仁和桃仁,浸透后一同煎煮,过滤取一次煎煮汁;余下混合液均分两份,按时间顺序每份加入前次滤出物料再次煎煮,过滤取煎煮汁,三次煎煮汁合一。
本专利申请的药食同源植物型饮料,其原料相关特性分别为:
蒲公英,食用中兼备的药用作用包括有:具体的对胃及十二指肠溃疡、上呼吸道感染、眼结膜炎、流行性腮腺炎、乳痈肿痛、胃炎、痢疾、肝炎、胆襄炎、急性阑尾炎、泌尿系感染、盆腔炎、痈疖疔疮、咽炎、急性乳腺炎、淋巴腺炎、瘰疠、疔毒疮肿、急性结膜炎、感冒发热、急性扁桃体炎的清热解毒,消肿散结作用,主要有利尿、退黄疸、利胆、助消化、增食欲效果,在防治癌、胃癌、食管癌及各种肿癌中发挥着功效。
玉竹食用中兼备滋补作用,对人体养阴清热、生津止咳、补益五脏,滋养气血、平补而润,兼除风热、养阴、润燥、除烦、止渴、降血糖、降血脂等效用,滋养镇静神经和强心虚劳发热、热病伤阴、虚热燥咳、心脏病、糖尿病、结核病、心悸、心绞痛等发挥着作用,还能够消谷易饥、改变小便数频状态。
佛手,食用中兼备的药用包括舒肝、健脾、和胃及理气化痰、止咳消胀等,常用于治疗肝郁气滞、肝胃气滞和胃止痛、胸胁胀痛、胃脘痞满、食少呕吐、舌苔厚腻。
栀子,食用中兼备的药用包括护肝利胆、泻火除烦、凉血解毒清热利湿、解毒利尿、降压镇静、止血、消肿,用于散瘀清热、黄疸尿赤、传染性肝炎、扭伤、高血压、糖尿病等症。
马齿苋 ,食用中兼备的药用包括清热解、利水去湿、散血消肿、除尘杀菌、消炎止痛、凉血止血、热毒血痢、痈肿疔疮、湿疹、丹毒、蛇虫咬伤、便血、痔血、崩漏下血,含大量的去甲肾上腺素,调节人体内糖代谢、改善脂质代谢的紊乱,能延长四氧嘧啶所致严重糖尿病生命,但不影响血糖水平。
玫瑰茄,食用中兼备的药用包括降血压、抗坏血病和利尿,有平肝降火、清热消炎、生津止渴、降压减脂、醒脑安神、清除自由基等作用,其含有的黄酮类化合物有清降血脂、胆固醇、甘油三酯的作用,有治疗高血糖高血脂病症、动脉硬化、高血压、达到防治心血管疾病的功效,有益于调节和平衡血脂、增进钙质吸收、促进儿童发育、促进消化等。
桑葚,其食用中兼备的药用包括护肝养肾、利水消肿、生津润燥、滋阴补血、清肝明目、安神解酒、养血乌发、延缓衰老、润肠通便、安神镇魄等,用于调节免疫、促进造血细胞生长、抗诱变、抗衰老、降血糖、降血脂、护肝等作用。
决明子,其食用中兼备的药用包括清肝明目、降血压、降血脂、降低血清、胆固醇和甘油三脂,益肾利便、润肠通便、抗菌、降脂瘦身等作用,治目赤肿痛、高血压、肝炎、肝硬化腹水、羞明泪多、头痛头晕、视物昏暗。
莱菔子,其食用中兼备的药用包括解毒、降压、消食除胀、降气化痰,用于抗病原微生物、饮食停滞、脘腹胀痛、大便秘结、积滞泻痢、痰壅喘咳。
陈皮,其食用中兼备的药用包括理气和中、燥湿化痰、利水通便的功效,调理脾胃不和、脘腹胀痛、不思饮食、呕吐哕逆、痰湿阻肺、咳嗽痰多、胸膈满闷、头目眩晕、水肿、小便不利、大便秘结、乳痈疥癣、中鱼蟹毒、酒毒,有预防高血脂症引起的动脉硬化、增强抗炎作用。
葛根,其食用中兼备的药用包括防治心肌缺血,对心肌代谢产生有益作用,扩张血管、营养心肌的氧代谢、改善微循环、降低血管阻力使血流量增加,防心肌梗死、心律失常、高血压、动脉硬化等病症,具有降糖、降脂、降低血清胆固醇、降低油三酯、治疗高血糖、高血脂病症,有益智作用,可治疗老年性痴呆、智力障碍、记忆力差等病症。
山楂,含有山萜类及黄铜类成份,具有显著的扩张血管及降压作用,有增强心肌、抗心律不齐、调节血脂及胆固醇含量的功能,含多种维生素、山楂酸、酒石酸、柠檬酸、苹果酸、黄酮类、内酯、糖类、蛋白质、脂肪和钙、磷、铁等矿物质,有健脾开胃、消积化滞、收敛止痢、活血化淤等功效,用于饮食积滞、胸膈痞满、疝气血淤等症。
桃仁,其食用中兼备的药用包括活血祛瘀、润肠通便、润燥滑肠的功效,治经闭、痛经、瘕瘕痞块、跌打损伤、肠燥便秘,。
火麻仁,能提供人体膳食中必需脂肪酸、氨基酸,含有很高的可降低胆固醇的植物甾醇,其食用中兼备的药用包括用于血虚津亏、体质较为虚弱、津血枯少、肠燥便秘、润燥杀虫。
枳椇子,其食用中兼备的药用包括抗脂质过氧化和降低血压、生津止渴、清热除烦,增强人体的抗病能力,有促进尿液排泄、加速肠道蠕动、通利二便的作用。
砂仁,其食用中兼备的药用包括抗血小板凝集作用、抗溃疡作用、促进消化液的分泌、增进肠道运动、排出消化管内的积气作用和功效,用于脾胃气滞、湿阻中焦、脾胃虚寒、呕吐泻泄。
本专利申请提供的药食同源植物型饮料及其制备方法技术方案,选用被国家卫计委列为药食同源目录中的十六种天然植物原料,对它们实施不同工艺、分别处理,再有机集中,克服了多种原料直接混合获得提取液出现的质感浑浊不清、口感味道混杂、药性味强烈、不清爽、提升品质工艺复杂的技术问题。本饮料制备方法相比现有技术提高了成份提取率,且成品具有淡爽的复配药香味,且留香持久,有深红葡萄洒之红中散透着金黄的成色,无需实施过滤工艺即呈现清澈、透明的质感,具有食疗特医作用的饮料品质,其食疗特医功能包括:具有清热解毒、消肿散结、清肝明目、护肝利胆、泻火除燥、凉血解毒作用;可以日常饮用40 -100 ml,有明显的降血脂、降低血清胆固醇和甘油三脂效果,对脂肪肝、酒精肝、高血脂、血稠血黏、便秘干燥、有显著的食疗作用,对中风血栓有辅助调节作用,解醉酒醉身。
具体实施方式
以下实施例是于上述总技术方案的一具体实施例,但本专利申请的保护范围不受本实施例所限,上述总技术方案具有同样的可实施和技术效果。
本专利申请的药食同源植物型饮料的制备方法,其原料按干料重量(具体重量单位)计分别为:
蒲公英 20-40份
佛手 5-10份
马齿苋 7-12份
玉竹 20-40份
栀子 7-12份
葛根 5-12份
莱菔子 10-20份
桑葚 10-20份
玫瑰茄 50-90份
山楂 20-40份
枳椇子 5-12份
桃仁 3-9份
决明子 5-15份
砂仁 5-12份
火麻仁 5-12份
橘皮 5-12份
其制备工艺方法:
其制备工艺方法:
第①步,加水5Kg,浸泡洗净后的玫瑰茄700g、栀子100g,浸泡不少于24小时,过滤取其浸液,备用;
第②步,佛手70g、玉竹300g、橘皮70g、砂仁70g和葛根70g清理干净,粉碎至黄豆颗粒大小,加入莱菔子150g,置入容器中加水5Kg浸泡12小时以上,然后共同置入高压釜中,压力0.2MPa以上隔水蒸制10分钟,降至室温后,过滤取蒸液,备用; 利用高压蒸汽温度大于120℃对原料蒸制提取的方法,大大提高了原料成份的提取率,同时降低了原料本身特殊味道对饮料的影响,还达到了提升提取液的澄清度的技术目的;
第③步,蒲公英300g、马齿苋100g、山楂300g、桑葚150g洗净,加水3Kg浸泡2小时至发软后,加小火煎煮20分钟,过滤取煎煮液,一次煎煮后的滤出物料补新水1Kg实施二次煎煮,过滤取二次煎煮液,二次煎煮后的滤出物料补新水1Kg实施三次煎煮,过滤取煎煮液,三次煎煮液合一,备用;
第④步,将第①、②、③步的浸液3Kg、蒸液1Kg和煎煮液3Kg混合,备用;
第⑤步,用第④步的5Kg混合液浸泡洗净的决明子70g、枳椇子70g、火麻仁70g和桃仁50g,浸泡12小时后一同小火煎煮20分钟,过滤取一次煎煮汁;余下混合液均分为两份,按时间顺序每份与其前次滤出物料再次煎煮,过滤取煎煮汁,将煎煮汁合一,由甜酸添加剂,调配口感,常规杀菌、灌装制备得到。
第⑤步采用混合液渗透提取方法,能够将各原料中的功用成份更好的有机融合,有助于大幅度减轻简单混合制备存在药味混浊的技术问题,而且混合液浸透方法还大大降低了煎制的能源消耗和用水的成本,增加了饮料汁的澄清度、提升了口感。
Claims (8)
1.一种药食同源植物型饮料,其特征在于,该饮料为蒲公英、玉竹、马齿苋、葛根、莱菔子、栀子、枳椇子、山楂、火麻仁、砂仁、决明子、桃仁、玫瑰茄、佛手、桑葚、橘皮的混合提取液,添加甜度调节添加剂制备得到。
2.一种权利要求1所述的药食同源植物型饮料的制备方法,其原料按绝干重量份计,分别为:
蒲公英 20-40份
佛手 5-10份
马齿苋 7-12份
玉竹 20-40份
栀子 7-12份
葛根 5-12份
莱菔子 10-20份
桑葚 10-20份
玫瑰茄 50-90份
山楂 20-40份
枳椇子 5-12份
桃仁 3-9份
决明子 5-15份
砂仁 5-12份
火麻仁 5-12份
橘皮 5-12份
其制备工艺方法:
第①步,加水,浸泡洗净后的玫瑰茄、栀子,浸泡不少于24小时,过滤取其浸液,备用;
第②步,佛手、玉竹、橘皮、砂仁和葛根清理干净,粉碎至黄豆颗粒大小,加入莱菔子,置入容器中加水浸泡至发软后,再隔水加压蒸制,过滤取蒸液,备用;
第③步,蒲公英、马齿苋、山楂、桑葚洗净,加水浸泡至发软后煎煮,过滤取煎煮液,备用;
第④步,将第①、②、③步的浸液、蒸液和煎煮液混合,备用;
第⑤步,用第④步的混合液的一部分浸泡洗净的决明子、枳椇子、火麻仁和桃仁,浸透后一同煎煮,过滤取一次煎煮汁;余下混合液至少一次与前次滤出物料再次煎煮,过滤取煎煮汁,将煎煮汁合一,由甜酸添加剂,调配口感,常规杀菌、灌装制备得到。
3.根据权利要求2所述的制备方法,其特征在于,第②步的加压蒸制工艺为:压力不低于0.2MPa蒸制10分钟。
4.根据权利要求2所述的制备方法,其特征在于,第③步为小火煎煮20分钟。
5.根据权利要求2或4所述的制备方法,其特征在于,第③步为三次煎煮,一次煎煮后的滤出物料补新水实施二次煎煮,过滤取二次煎煮液,二次煎煮后的滤出物料补新水实施三次煎煮,过滤取三次煎煮液,三次煎煮液合一。
6.根据权利要求5所述的制备方法,其特征在于,每次补水量不超过第一次加水量的1/3。
7.根据权利要求2所述的制备方法,其特征在于,第①步的浸液、第②步的蒸液、第③步的煎煮液,按重量比1:1-2:1-2混合,得混合液。
8.根据权利要求2所述的制备方法,其特征在于,其第⑤步,用不少于第④步混合液的一半浸泡洗净的决明子、枳椇子、火麻仁和桃仁,浸透后一同煎煮,过滤取一次煎煮汁;余下混合液均分两份,按时间顺序每份加入前次滤出物料再次煎煮,过滤取煎煮汁,三次煎煮汁合一。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010583106.4A CN111685244A (zh) | 2020-06-24 | 2020-06-24 | 药食同源植物型饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010583106.4A CN111685244A (zh) | 2020-06-24 | 2020-06-24 | 药食同源植物型饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111685244A true CN111685244A (zh) | 2020-09-22 |
Family
ID=72483565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010583106.4A Pending CN111685244A (zh) | 2020-06-24 | 2020-06-24 | 药食同源植物型饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111685244A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114617212A (zh) * | 2022-03-18 | 2022-06-14 | 宋勇华 | 药食同源类植物配伍功能饮品饮料及其制备方法 |
CN114947029A (zh) * | 2021-02-25 | 2022-08-30 | 陕西罗麻丹医药有限公司 | 一种调理心脏病的固体饮料及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030008055A1 (en) * | 1999-08-17 | 2003-01-09 | Tadashi Hashimoto | Production process for drinks |
CN104095117A (zh) * | 2014-06-16 | 2014-10-15 | 胡安然 | 一种防治肝炎的茶 |
CN105942051A (zh) * | 2016-04-27 | 2016-09-21 | 王顺 | 一种药食两用植物饮料及其制备方法 |
CN106362117A (zh) * | 2016-10-25 | 2017-02-01 | 深圳市华岁堂健康药业有限公司 | 解酒养肝的中药组合物及其制备方法 |
CN107050189A (zh) * | 2017-05-09 | 2017-08-18 | 冯海强 | 一种黑枸杞加药食同源中药伴侣制品以及制备方法 |
CN108371694A (zh) * | 2018-01-20 | 2018-08-07 | 江西永昇制药股份有限公司 | 复方蒲公英癌症养护期中药配方 |
CN109953257A (zh) * | 2017-12-25 | 2019-07-02 | 山东御膳世家生物科技有限公司 | 一种五行三十九味营养品及其制备工艺 |
CN110522872A (zh) * | 2019-08-23 | 2019-12-03 | 湖北中医药大学 | 一种调养身体的膏滋组合物及其制备方法 |
-
2020
- 2020-06-24 CN CN202010583106.4A patent/CN111685244A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030008055A1 (en) * | 1999-08-17 | 2003-01-09 | Tadashi Hashimoto | Production process for drinks |
CN104095117A (zh) * | 2014-06-16 | 2014-10-15 | 胡安然 | 一种防治肝炎的茶 |
CN105942051A (zh) * | 2016-04-27 | 2016-09-21 | 王顺 | 一种药食两用植物饮料及其制备方法 |
CN106362117A (zh) * | 2016-10-25 | 2017-02-01 | 深圳市华岁堂健康药业有限公司 | 解酒养肝的中药组合物及其制备方法 |
CN107050189A (zh) * | 2017-05-09 | 2017-08-18 | 冯海强 | 一种黑枸杞加药食同源中药伴侣制品以及制备方法 |
CN109953257A (zh) * | 2017-12-25 | 2019-07-02 | 山东御膳世家生物科技有限公司 | 一种五行三十九味营养品及其制备工艺 |
CN108371694A (zh) * | 2018-01-20 | 2018-08-07 | 江西永昇制药股份有限公司 | 复方蒲公英癌症养护期中药配方 |
CN110522872A (zh) * | 2019-08-23 | 2019-12-03 | 湖北中医药大学 | 一种调养身体的膏滋组合物及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114947029A (zh) * | 2021-02-25 | 2022-08-30 | 陕西罗麻丹医药有限公司 | 一种调理心脏病的固体饮料及其制备方法 |
CN114617212A (zh) * | 2022-03-18 | 2022-06-14 | 宋勇华 | 药食同源类植物配伍功能饮品饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106213101A (zh) | 一种发酵型果蔬汁 | |
CN105901715A (zh) | 一种鹿胶糕及其制备方法 | |
CN106805176A (zh) | 秋葵多糖保健果冻及其制备方法 | |
CN104928141A (zh) | 一种黑果枸杞蜂蜜果酒的制备方法 | |
CN105212219A (zh) | 一种含桑葚的复合营养粉及其制备方法 | |
CN101731711B (zh) | 鲜鱼腥草梨汁饮料及其制作方法 | |
CN111685244A (zh) | 药食同源植物型饮料及其制备方法 | |
CN104207241B (zh) | 一种药食同源复合保健饮料及其制备方法 | |
CN105919099A (zh) | 一种利用葛根、桑葚制备酵素的方法 | |
CN101322550B (zh) | 一种食疗保健醋及其制备方法 | |
CN110226688A (zh) | 一种桑葚黄精饮品及其制备方法 | |
CN106343091A (zh) | 一种减肥瘦身茶凉茶饮料及其制备方法 | |
CN103609695A (zh) | 降压祛火的酸奶及其制备方法 | |
CN109364227A (zh) | 一种调理血瘀质症状的健康养生食品及其制备方法 | |
CN106036690A (zh) | 一种蜜醋黑豆果冻及制备方法 | |
CN104938952A (zh) | 一种清凉口感的糯米糕及其制备方法 | |
CN1332016C (zh) | 一种石榴干酒的酿造工艺 | |
CN110184157B (zh) | 以桑葚发酵酒为酒基加入鹿血、黄精的露酒及其制备方法 | |
CN111234994A (zh) | 一种保健酒的制备方法 | |
CN112674342A (zh) | 一种保健果酸汤及其制备方法 | |
CN111690496A (zh) | 一种山楂百香果酒 | |
CN105341579A (zh) | 一种提高免疫力的保健饮料及其制备方法 | |
CN110507770A (zh) | 一种双叶薏枣清降代用茶 | |
CN104195001A (zh) | 一种山楂酒及其制备方法 | |
CN1090499C (zh) | 一种纯天然植物解酒健身茶 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |